lundi 15 mai 2017

Onco Actu du 15 mai 2017

4.1 Dép., diag. & prono. - Prostate

Myriad Genetics' Prolaris® Test Accurately Predicts the 10-Year Risk of Metastases in Men Treated for Prostate Cancer [Myriad]

Myriad touts 10-year data for prostate cancer screen [FierceBiotech]

4.2 Dép., diag. & prono. - Génome

New Gene Tests Pose a Threat to Insurers [NY Times]

New Gene Tests Pose a Threat to Insurers [NY Times]

5. Traitements

NCI ALMANAC: A New Tool for Research on Cancer Drug Combinations [NCI]

5.12 Immunothérapies

Competition between immune cells could explain why some immunotherapy drugs fail [Cancer Research UK]

Turmoil in Immuno-oncology [in the Pipeline]

5.12.5 Immunothérapies - Pharma

AstraZeneca gains major I-O ground with Imfinzi lung cancer maintenance stunner [FiercePharma]

AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next [Forbes]

AstraZeneca’s shares spike on a surprise coup in PhIII lung cancer data [EndPoints]

5.2 Pharma

IMBRUVICA® (ibrutinib) Pooled Outcomes Data from Three Phase 3 Studies Suggest Potential Clinical Efficacy in Patients with High-Risk Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [AbbVie]

5.2.1 Pharma - Partenariats

Clinigen partners with Tesaro’s PARP med for European preapproval access [FiercePharma]

6.2 Implants mammaires

French court orders TÜV to pay damages for faulty breast implants [Reuters]

A Shocking Diagnosis: Breast Implants ‘Gave Me Cancer’ [NY Times]

What You Need to Know if You Have Breast Implants [NY Times]

6.3 Associations/Fondations

We ran a national cancer conference with two staff [The Guardian]

6.7 DMP, Big Data & applis

If You Still Use Windows XP, Prepare For the Worst [Wired]

The Ransomware Meltdown Experts Warned About Is Here [Wired]

Jeremy Hunt 'ignored warning signs' before cyber-attack hit NHS [The Guardian]